Nuwellis (NUWE) Revenue Growth (3y) (2016 - 2026)
Nuwellis (NUWE) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 17.14% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.92% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 9.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.58% |
| Dec 31, 2025 | 1.20% |
| Sep 30, 2025 | 2.40% |
| Jun 30, 2025 | -7.97% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 8.50% |
| Jun 30, 2024 | -4.36% |
| Mar 31, 2024 | -1.07% |
| Dec 31, 2023 | 7.67% |
| Sep 30, 2023 | 8.20% |
| Jun 30, 2023 | 3.66% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | 19.61% |
| Sep 30, 2022 | 18.15% |
| Jun 30, 2022 | 9.69% |
| Mar 31, 2022 | 16.60% |
| Dec 31, 2021 | 3.08% |
| Sep 30, 2021 | 10.78% |
| Jun 30, 2021 | 31.66% |